The "dysharmonic luteal phase" syndrome: endometrial progesterone receptor and estradiol dehydrogenase.
The dysharmonic luteal phase (DLP) syndrome is defined by delayed endometrial maturation despite normal plasma progesterone (P) values. In ten patients with DLP the actual date of the endometrial biopsy, dated retrospectively, was 24.7 +/- 2.3 days, whereas the histologic date was 20.0 +/- 2.6 days. The concentration of cytosolic P receptor in DLP endometrium tended to be lower, whereas the concentration of nuclear receptor was significantly higher in DLP than in seven matched patients with normal luteal phases. Endometrial estradiol-dehydrogenase activities were identical in both groups. The DLP syndrome cannot be explained by a decreased sensitivity of the endometrium to P and is probably merely functional in nature.
D015067:17-Hydroxysteroid Dehydrogenases / Q000032:analysis*; D000328:Adult; D001706:Biopsy; D004717:Endometrium / Q000032:analysis* / Q000473:pathology; D004958:Estradiol / Q000097:blood; D004960:Estradiol Dehydrogenases / Q000032:analysis*; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D008183:Luteal Phase; D011374:Progesterone / Q000032:analysis* / Q000097:blood; D011980:Receptors, Progesterone / Q000032:analysis*; D013194:Staining and Labeling
D011980:Receptors, Progesterone; D011374:Progesterone; D004958:Estradiol; D015067:17-Hydroxysteroid Dehydrogenases; D004960:Estradiol Dehydrogenases